Controversy regarding the CYP2D6 activity score range and predicted phenotype for the risperidone metabolism rate between “the consortium (CPIC + DPWG)” and “the PPM-pharmacogenomics of autism spectrum disorders of Thailand Project.” This evidence concerns the gene CYP2D6 and autism spectrum disorder.